{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:59:45Z","timestamp":1793977185225,"version":"4.8.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIA","award":["P01AG14449"],"award-info":[{"award-number":["P01AG14449"]}]},{"name":"NIA","award":["R01AG043375"],"award-info":[{"award-number":["R01AG043375"]}]},{"name":"NIA","award":["P30AG010161"],"award-info":[{"award-number":["P30AG010161"]}]},{"name":"NIA","award":["P30AG019610"],"award-info":[{"award-number":["P30AG019610"]}]},{"name":"Arizona Alzheimer's Disease Consortium at Barrow Neurological Institute","award":["ADHS14-052688"],"award-info":[{"award-number":["ADHS14-052688"]}]},{"DOI":"10.13039\/100013014","name":"Barrow Neurological Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013014","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.neurobiolaging.2017.02.012","type":"journal-article","created":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T01:34:45Z","timestamp":1489023285000},"page":"133-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Neocortical and hippocampal TREM2 protein levels during the progression of Alzheimer's disease"],"prefix":"10.1016","volume":"54","author":[{"given":"Sylvia E.","family":"Perez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Nadeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer C.","family":"Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Malek-Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kewei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliott J.","family":"Mufson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib1","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.neurobiolaging.2012.12.018","article-title":"TREM2 is associated with the risk of Alzheimer's disease in Spanish population","volume":"34","author":"Benitez","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib2","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/01.wnl.0000219668.47116.e6","article-title":"Neuropathology of older persons without cognitive impairment from two community-based studies","volume":"66","author":"Bennett","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib3","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archneur.61.3.378","article-title":"Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function","volume":"61","author":"Bennett","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib4","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neuron.2010.10.013","article-title":"The genetics of Alzheimer disease: back to the future","volume":"68","author":"Bertram","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/B:CEMN.0000012721.08168.ee","article-title":"Nasu-Hakola disease (polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy\u2014PLOSL): a dementia associated with bone cystic lesions. From clinical to genetic and molecular aspects","volume":"24","author":"Bianchin","year":"2004","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13148-016-0202-9","article-title":"TREM2 upregulation correlates with 5-hydroxymethylcytosine enrichment in Alzheimer's disease hippocampus","volume":"8","author":"Celarain","year":"2016","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/humu.20836","article-title":"Mutations in TREM2 lead to pure early-onset dementia without bone cysts","volume":"29","author":"Chouery","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nri1106","article-title":"TREMs in the immune system and beyond","volume":"3","author":"Colonna","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib10","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/glia.20710","article-title":"TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice","volume":"56","author":"Frank","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3233\/JAD-2010-101080","article-title":"Regional selectivity of rab5 and rab7 protein upregulation in mild cognitive impairment and Alzheimer's disease","volume":"22","author":"Ginsberg","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib12","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.neurobiolaging.2013.02.016","article-title":"Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease","volume":"34","author":"Giraldo","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"TREM2 variants in Alzheimer's disease","volume":"368","author":"Guerreiro","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/jamaneurol.2013.579","article-title":"Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement","volume":"70","author":"Guerreiro","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib15","first-page":"1","article-title":"Neuropsychiatric and genetic aspects of a new hereditary disease characterized by progressive dementia and lipomembranous polycystic osteodysplasia","volume":"232","author":"Hakola","year":"1972","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13195-016-0182-1","article-title":"Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease","volume":"8","author":"Henjum","year":"2016","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13024-016-0071-x","article-title":"Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease","volume":"11","author":"Heslegrave","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib18","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1038\/npp.2014.164","article-title":"Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer's disease","volume":"39","author":"Jiang","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fncel.2014.00094","article-title":"Regulating amyloidogenesis through the natural triggering receptor expressed in myeloid\/microglial cells 2 (TREM2)","volume":"8","author":"Jones","year":"2014","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","article-title":"Variant of TREM2 associated with the risk of Alzheimer's disease","volume":"368","author":"Jonsson","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib21","doi-asserted-by":"crossref","first-page":"243ra86","DOI":"10.1126\/scitranslmed.3009093","article-title":"TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis","volume":"6","author":"Kleinberger","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib22","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/ni1411","article-title":"The TREM receptor family and signal integration","volume":"7","author":"Klesney-Tait","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib23","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.neurobiolaging.2014.04.010","article-title":"Homozygous TREM2 mutation in a family with atypical frontotemporal dementia","volume":"35","author":"Le Ber","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/bpa.12190","article-title":"TREM2 protein expression changes correlate with Alzheimer's disease neurodegenerative pathologies in post-mortem temporal cortices","volume":"25","author":"Lue","year":"2015","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13024-016-0137-9","article-title":"Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer's disease brains","volume":"11","author":"Ma","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib26","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.celrep.2014.12.041","article-title":"A\u00a0genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology","volume":"10","author":"Matarin","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib27","doi-asserted-by":"crossref","first-page":"e00037","DOI":"10.1042\/AN20100010","article-title":"Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease","volume":"2","author":"Melchior","year":"2010","journal-title":"ASN Neuro."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib28","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/S0197-4580(97)00058-4","article-title":"The CERAD neuropathology protocol and consensus recommendations for the postmortem diagnosis of Alzheimer's disease: a commentary","volume":"18","author":"Mirra","year":"1997","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib29","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1177\/002215540004801206","article-title":"Novel method to quantify neuropil threads in brains from elders with or without cognitive impairment","volume":"48","author":"Mitchell","year":"2000","journal-title":"J.\u00a0Histochem. Cytochem."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00401-011-0884-1","article-title":"Mild cognitive impairment: pathology and mechanisms","volume":"123","author":"Mufson","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib32","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/NEN.0b013e318272caab","article-title":"Hippocampal proNGF signaling pathways and \u03b2-amyloid levels in mild cognitive impairment and Alzheimer disease","volume":"71","author":"Mufson","year":"2012","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neuroscience.2015.03.006","article-title":"Hippocampal plasticity during the progression of Alzheimer's disease","volume":"309","author":"Mufson","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neurobiolaging.2016.03.003","article-title":"Braak stage and trajectory of cognitive decline in noncognitively impaired elders","volume":"43","author":"Mufson","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib35","first-page":"539","article-title":"A\u00a0lipid metabolic disease-\u201cmembranous lipodystrophy\u201d\u2014an autopsy case demonstrating numerous peculiar membrane-structures composed of compound lipid in bone and bone marrow and various adipose tissues","volume":"23","author":"Nasu","year":"1973","journal-title":"Acta Pathol. Jpn."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib36","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/brain\/awn109","article-title":"Debris clearance by microglia: an essential link between degeneration and regeneration","volume":"132","author":"Neumann","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib37","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/00005072-199911000-00004","article-title":"Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease","volume":"58","author":"Newell","year":"1999","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib38","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13024-015-0040-9","article-title":"TREM2 in CNS homeostasis and neurodegenerative disease","volume":"10","author":"Painter","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib39","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ajpath.2011.10.027","article-title":"Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease","volume":"180","author":"Perez","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib40","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.biopsych.2013.12.016","article-title":"Resilience of precuneus neurotrophic signaling pathways despite amyloid pathology in prodromal Alzheimer's disease","volume":"77","author":"Perez","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2741\/E605","article-title":"Genetics of familial and sporadic Alzheimer's disease","volume":"5","author":"Piaceri","year":"2013","journal-title":"Front Biosci."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib42","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00401-016-1533-5","article-title":"Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status","volume":"131","author":"Piccio","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-122311","article-title":"TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease","volume":"35","author":"Pottier","year":"2013","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib44","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3233\/JAD-160663","article-title":"Neuroprotective effect of TREM-2 in aging and Alzheimer's disease model","volume":"55","author":"Raha","year":"2016","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib45","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s12017-015-8376-4","article-title":"Genetic factors affecting late-onset Alzheimer\u2019s disease susceptibility","volume":"18","author":"Rezazadeh","year":"2016","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s40142-014-0034-x","article-title":"Late-onset Alzheimer's disease genes and the potentially implicated pathways","volume":"2","author":"Rosenthal","year":"2014","journal-title":"Curr. Genet. Med. Rep."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib47","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1046\/j.1471-4159.2002.01243.x","article-title":"Heterogeneous expression of the triggering receptor expressed on myeloid cells-2 on adult murine microglia","volume":"83","author":"Schmid","year":"2002","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib48","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1111\/j.1460-9568.2004.03729.x","article-title":"Distribution and signaling of TREM2\/DAP12, the receptor system mutated in human polycystic lipomembraneous osteodysplasia with sclerosing leukoencephalopathy dementia","volume":"20","author":"Sessa","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib49","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jalz.2014.05.1751","article-title":"R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia","volume":"10","author":"Slattery","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib50","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00702-015-1369-5","article-title":"Changes in the expression of genes related to neuroinflammation over the course of sporadic Alzheimer's disease progression: CX3CL1, TREM2, and PPAR\u03b3","volume":"122","author":"Strobel","year":"2015","journal-title":"J.\u00a0Neural. Transm."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib51","first-page":"369ra178","article-title":"sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers","volume":"8","author":"Su\u00e1rez-Calvet","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib52","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1084\/jem.20041611","article-title":"Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2","volume":"201","author":"Takahashi","year":"2005","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib53","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1750-1326-9-20","article-title":"Altered microglial response to A\u03b2 plaques in APPPS1-21 mice heterozygous for TREM2","volume":"9","author":"Ulrich","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib54","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/jmg.34.9.753","article-title":"Nasu-Hakola syndrome: polycystic lipomembranous osteodysplasia with sclerosing leucoencephalopathy and presenile dementia","volume":"34","author":"Verloes","year":"1997","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib55","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","article-title":"TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model","volume":"160","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib56","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1084\/jem.20151948","article-title":"TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques","volume":"213","author":"Wang","year":"2016","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib57","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","article-title":"TREM2 Binds to apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-beta by microglia","volume":"91","author":"Yeh","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib58","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.neuron.2016.05.003","article-title":"TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy","volume":"90","author":"Yuan","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2017.02.012_bib59","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/WNR.0b013e32835fb6b0","article-title":"Regulation of TREM2 expression by an NF-\u043aB-sensitive miRNA-34a","volume":"24","author":"Zhao","year":"2013","journal-title":"Neuroreport"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458017300568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458017300568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T14:23:35Z","timestamp":1535984615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458017300568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":59,"alternative-id":["S0197458017300568"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.02.012","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neocortical and hippocampal TREM2 protein levels during the progression of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}